Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects

NCT02268838 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: E6007
DRUG: E6007 matching placebo

Sponsor

Eisai Co., Ltd.